Azidothymidine induces apoptosis in mouse myeloma cell line Sp2/0

Biochemical Pharmacology

Volumn 52, Issue 6, 1996, Pages 857-862

  Sailaja, G ^a   Nayak, R ^a   Antony, A ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

apoptosis; azidothymidine; endonuclease; poly(ADP ribose)polymerase

Indexed keywords

ANTIVIRUS AGENT; CALCIUM; DNA; DOUBLE STRANDED DNA; ENDONUCLEASE; MAGNESIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; THYMIDINE; URIDINE; ZIDOVUDINE; ZINC ACETATE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CLEAVAGE; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; MOUSE; MYELOMA CELL; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL;

EID: 0030603974     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)82183-6     Document Type: Article

References (33)

1. 1. Mitsuya H, Weinhold KJ, Furman PA, St. Clair MH, Nusinoss-Lehrman S, Gallo RC, Bolognesi D, Barry DW and Broder S, 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 82: 7096-7100, 1985.
2. 2. Furman PA, Fyfe JA, St. Clair MH, Weinhold K, Rideout JL, Freeman GA, Nusinoss-Lehrman S, Bolognesi DP, Broder S, Mitsuya H and Barry DW, Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodefficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83: 8333-8337, 1986.
3. 3. Zimmerman TP, Mahony WB and Prus KL, 3′-Azido-3′-deoxythymidine. J Biol Chem 262: 5748-5754, 1987.
4. 4. Copeland WC, Chen MS and Wang TSF, Human DNA polymerases α and β are able to incorporate anti-HIV deoxynucleotides into DNA. J Biol Chem 267: 21459-21464, 1992.
5. 5. Konig H, Behr E, Lower J and Kurth R, Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type I reverse transcriptase and DNA polymerase gamma. Antimicrob Agents Chemother 33: 2109-2114, 1989.
6. 6. Richman DD, Fischl MA, Grieco MH, Gottieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S and the AZT Collaborative Working Group, The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. N Engl J Med 317: 192-197, 1987.
7. 7. Sommadossi JP, Carlisle R and Zhou Z, Cellular pharmacology of 3′-azido-3′-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells. Mol Pharmacol 36: 9-14, 1989.
8. 8. Szebeni J, Patel SS, Hung K, Wahl LH and Weinstein JN, Effects of thymidine and uridine on the phosphorylation of 3′-azido-3′-deoxythymidine (Zidovudine) in human mononuclear cells. Antimicrob Agents Chemother 35: 198-200, 1991.
9. 9. Sommadossi JP, Carlisle R, Schinazi RF and Zhou Z, Uridine reverses the toxicity of 3′-azido-3′-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity. Antimicrob Agents Chemother 32: 997-1001, 1988.
10. 10. Agarwal RP and Mian AM, Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro. Biochem Pharmacol 42: 905-911, 1991.
11. 11. Harrington JA, Reardon JE and Spector T, 3′-Azido-3′-deoxythymidine (AZT) monophosphate: an inhibitor of exonucleolytic repair of AZT terminated DNA. Antimicrob Agents Chemother 37: 918-920, 1993.
12. 12. Frick LW, Nelson DJ, St. Clair MH, Furman PA and Krenitsky TA, Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154: 124-129, 1988.
13. 13. Fridland A, Connelly MC and Ashmun R, Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiviral agent 3′-azido-3′-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM). Mol Pharmacol 37: 665-670, 1990.
14. 14. Kwok JBJ and Tattersall MHN, DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine. Br J Cancer 65: 503-508, 1992.
15. 15. Kerr JFR, Winterford CM and Harmon BV, Apoptosis: Its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
16. 16. Wyllie AH, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-556, 1980.
17. 17. Barry MA, Behnke CA and Eastman A, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
18. 18. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D and Boyd MR, Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48: 4827-4833, 1988.
19. 19. Miller SA, Dykes DD and Polesky HF, A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16: 1215, 1988.
20. 20. Ucker DS, Obermiller PS, Eckhart W, Apgar JR, Berger NA and Meyers J, Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol 12: 3060-3069, 1992.
21. 21. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ, Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
22. 22. Yhoshihara K, Itaya A, Hironaka T, Sakuramoto S, Tanaka Y, Tsuyuki M, Inada Y, Kamiya T, Ohnishi K, Honma M, Katovoka E, Mizusawa H, Uchida M, Uchida K and Miwa M, Poly(ADP ribose)polymerase-defective mutant cell clone of mouse L1210 cells. Exp Cell Res 200: 126-134, 1992.
23. 23. Sen S and D'Incalci M, Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS Lett 307: 122-127, 1992.
24. 24. Cohen JJ and Duke RC, Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 132: 38-42, 1984.
25. 25. Walker RP, Weaver VM, Lach B, Leblanc J and Sikorska M, Endonuclease activities associated with high molecular weight and intranucleosomal DNA fragmentation in apoptosis. Exp Cell Res 213: 100-106, 1994.
26. 26. Peitsch MC, Polzar B, Stephan H, Cromton T, MacDonald HR, Mannherz HG and Tschopp J, Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). EMBO J 12: 371-377, 1993.
27. 27. Tanizawa A, Kubota M, Hashimoto H, Shimizu T, Takimoto T, Kitoh T, Akiyama Y and Mikava H, VP-16-induced nucleotide pool changes and poly (ADP-ribose) synthesis: The role of VP-16 in interphase death. Exp Cell Res 185: 237-246, 1989.
28. 28. Schraufstatter IU, Hyslop PA, Hinshaw DB, Spragg RG, Sklar LA and Cochrane CG, Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose)polymerase. Proc Natl Acad Sci USA 83: 4908-4912, 1986.
29. 29. Tanaka Y, Yoshihara K, Tsuyuki M and Kamiya T, Apoptosis induced by adenosine in human leukemia HL-60 cells. Exp Cell Res 213: 242-252, 1994.
30. 30. Nosseri C, Coppola S and Ghibelli L, Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp Cell Res 212: 367-373, 1994.
31. 31. Martin SJ, Lennon SV, Bornham AM and Cotter TG, Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145: 1859-1867, 1990.
32. 32. Yoshioka A, Tanaka S, Hiroka O, Koyama Y, Hiraota Y, Ayusawa D, Seno T, Garrett C and Wataya Y, Deoxyribonucleoside Triphosphate imbalance. J Biol Chem 262: 8235-8241, 1987.
33. 33. Kizaki H, Shimada H, Ohsaka F and Sakurada T, Adenosine, deoxyadenosine and deoxyguanosine induce DNA cleavage in mouse thymocytes. J Immunol 141: 1652-1657, 1988.